Retrospective Impact Analysis and Cost-Effectiveness of the Pneumococcal Conjugate Vaccine Infant Program in Australia

Australia introduced the 7-valent pneumococcal conjugate vaccine (7vPCV) on the universal infant National Immunisation Program (NIP) in 2005 and replaced it with the 13-valent pneumococcal conjugate vaccine (13vPCV) in 2011, both under a 3 + 0 schedule. The objective of this analysis was to quantify...

Descripción completa

Detalles Bibliográficos
Autores principales: Perdrizet, Johnna, Lai, Yuen S., Williams, Scott, Struwig, Valda A., Wasserman, Matt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7954941/
https://www.ncbi.nlm.nih.gov/pubmed/33575966
http://dx.doi.org/10.1007/s40121-021-00409-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7954941/
https://www.ncbi.nlm.nih.gov/pubmed/33575966
http://dx.doi.org/10.1007/s40121-021-00409-7

Ejemplares similares